Saturday, July 12, 2025 4:28:43 PM
When people talk about Bionano Genomics, they usually focus on things like FDA approval, new diagnostic tests, or how it’s changing the way genetic diseases are diagnosed. But behind the scenes, one of the biggest names in tech is quietly making it all run smoother… Microsoft.
Back in 2021, Bionano teamed up with Microsoft to help tackle a big challenge, how to process massive amounts of genetic data quickly and efficiently. Instead of relying solely on their own computing power, Bionano tapped into Microsoft’s cloud platform. That move cut their analysis time by nearly a third and saved them more than half of their compute costs. For researchers and doctors, that means faster answers and lower costs, which can translate to better care for patients.
This collaboration hasn’t been widely talked about, but it’s making a real difference. Microsoft’s cloud tech helps Bionano scale its reach, whether it’s analyzing complex genetic conditions or preparing for broader clinical use. While other headlines focus on market speculation and clinical milestones, this partnership is quietly helping Bionano become a more efficient and reliable player in the world of medical diagnostics.
Microsoft may not be in the spotlight here, but their tools are powering real change behind the scenes.
Bionano Genomics’ acquires, affiliations & partnerships: Microsoft, BioDiscovery, Diagens, Lineagen, Revvity, Hamilton, and Tecan. I think I have all of them?
BNGO $3.40
Recent BNGO News
- Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026 • GlobeNewswire Inc. • 03/09/2026 08:05:00 PM
- Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale • GlobeNewswire Inc. • 02/27/2026 01:00:00 PM
- 10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders • GlobeNewswire Inc. • 02/26/2026 01:00:00 PM
- 11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy • GlobeNewswire Inc. • 02/25/2026 01:00:00 PM
- 9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies • GlobeNewswire Inc. • 02/24/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:31:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:29:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:28:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:26:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:25:37 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 09:06:07 PM
- Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping • GlobeNewswire Inc. • 02/09/2026 02:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:19:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:18:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:17:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:16:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:14:16 PM
- Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies • GlobeNewswire Inc. • 02/04/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 01:15:51 PM
- Bionano Reports Preliminary Fourth Quarter and Full-Year 2025 Results • GlobeNewswire Inc. • 01/12/2026 01:00:00 PM
- Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025 • GlobeNewswire Inc. • 12/11/2025 01:00:00 PM
- Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies • GlobeNewswire Inc. • 12/03/2025 01:00:00 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
